U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07636512) titled 'Effectiveness and Safety of Cellbooster Shape in Healthy Subjects' on April 17.
Brief Summary: SUISSELLE has developed a CE marketed (2021) HA-based superficial epidermis/dermis injection filler and skinbooster product, Cellbooster(R) Shape (CBS). CBS is produced using patented CHAC Technology. It consists of non-crosslinked HA with L-Carnitine and vitamin C. The device is particularly designed for reducing local puffiness by improving microcirculation and hydration.
The current post-market clinical investigation is designed to evaluate the efficacy and safety of CBS. For this purpose, healthy subjects with signs of skin aging in t...